Subscribe To
Should you buy viking therapeutics stock after it skyrocketed over 60%?
Viking Therapeutics announced promising results on Tuesday from a phase 1 study of obesity drug VX2735....
March 29, 2023, 5:54 am
Here's why viking therapeutics rose over 50% on obesity drug data
Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GL...
March 28, 2023, 1:01 pm
Viking therapeutics steps into the obesity ring — and catapults 63%
Viking said Tuesday recipients of its potential obesity treatment lost up to 18 pounds, and VKTX stock ...
March 28, 2023, 12:32 pm
Viking therapeutics shares up more than 50% on positive trial results for obesity drug
Viking Therapeutics (NASDAQ:VKTX) shares had added more than 55% on Tuesday after the biopharmaceutical company published positive early-stage data fo...
March 28, 2023, 10:51 am
Biotech stock surges to 4-year highs on upbeat trial
Viking Therapeutics Inc (NASDAQ:VKTX) is surging, last seen up 53.7% at $14.02, after the company revealed plans to start a mid-stage trial for exper...
March 28, 2023, 10:12 am
Viking's stock rallies as it announces trial for oral version of obesity drug
Shares of Viking Therapeutics Inc. VKTX, +3.05% soared about 45% in premarket trading on Tuesday after the company said it started a Phase 1 clinical ...
March 28, 2023, 8:19 am
Is viking therapeutics a smart buy on the dip?
Shares of Viking Therapeutics fell 25.2% during the week that ended March 24. Viking Pharmaceuticals fell in sympathy with Adaptimmune, which is devel...
March 27, 2023, 5:47 am
The ozempic obesity battle is heating up with novo scoring a fresh win
Novo Nordisk stock popped Friday after higher doses of its popular drug, semaglutide, led to greater weight loss in diabetes patients. The post The Oz...
March 24, 2023, 2:37 pm
Altimmune (alt) stock down despite positive obesity study data
Altimmune (ALT) reports positive interim analysis data from a phase II obesity study of pemvidutide. Ho...
March 22, 2023, 1:00 pm
Wall street absolutely loved this biotech stock. but it just crashed more than 50%.
Analysts had lofty expectations for Altimmune and the prospects for pemvidutide in treating obesity. Ho...
March 22, 2023, 5:55 am
Economists warn of costs if us medicare covers new obesity drugs
By Nancy Lapid (Reuters) – The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new ...
March 11, 2023, 12:51 pm
Ww international ceo on weight loss drugs: still critical you make the right lifestyle changes
CNBC's Meg Tirrell talks with Sima Sistani, WW International CEO, on 'Closing Bell: Overtime' to discuss the company's stock surge after announcing it...
March 7, 2023, 5:16 pm
Weightwatchers stock surges 70% after company agrees to buy obesity treatment platform
WeightWatchers has agreed to acquire telehealth obesity treatment company Sequence....
March 7, 2023, 3:20 pm
Ww stock soars as telehealth deal opens up hot obesity drug market
Former WeightWatchers is entering clinical weight management. WW stock surged....
March 7, 2023, 7:12 am
Weight watcher' sales forecast comes up short, and subscribers are down. but it's reportedly buying its way into telehealth, with diabetes and obesity drugs
WW International Inc., the company that oversees the weight-loss program Weight Watchers, forecast first-quarter sales that were below expectations Mo...
March 6, 2023, 4:54 pm
Mineralys therapeutics presents positive lorundrostat results from the phase 2 target-htn trial at acc.23/wcc
Lorundrostat demonstrated clinically meaningful blood pressure reduction in individuals with uncontrolled hypertension ...
March 4, 2023, 9:30 pm
Altimmune's peptide-based therapies offer substantial opportunity
Altimmune is a pioneer in creating peptide-based therapies for obesity and liver disease, with a unique...
February 23, 2023, 3:09 am
Altimmune: potential dual action for pemvidutide in obesity, nash
Altimmune has exposure to promising growth areas of obesity and non-alcoholic liver disease treatment. ...
February 21, 2023, 7:35 pm
[latest] global weight loss and weight management market size/share worth usd 405.4 billion by 2030 at a 6.84% cagr: growing obesity rate to propel market growth – facts & factors (industry trends, re
The global weight loss and weight management market size was valued at USD 224.27 billion in 2021 and is expected to surpass USD 405.4 billion by 2030...
February 9, 2023, 8:14 am
There's a crop of great biotech companies ready to be acquired, says mpm's christiana bardon
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sec...
February 2, 2023, 3:15 pm